PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
During treatment for a Ewing tumor (Ewing sarcoma), the main concerns for most people and their families are the daily aspects of getting through treatment and beating the cancer. After treatment, the concerns tend to shift toward the long-term effects of the cancer and its treatment, as well as worries about the cancer coming back.
It’s certainly normal to want to put the tumor and its treatment behind you and to get back to a life that doesn’t revolve around cancer. But it’s important to realize that follow-up care is a central part of this process that offers the best chance for recovery and long-term survival.
Once treatment is finished, the health care team will discuss a follow-up schedule with you, including which tests should be done and how often. It’s very important to go to all follow-up appointments. Follow-up visits are needed to check for cancer recurrence, as well as possible side effects of treatment.
Physical exams, along with imaging tests (such as x-rays and CT, MRI, PET, and/or bone scans) are often done every 2 to 3 months for the first couple of years following treatment, and then less often over time if there are no issues. If Ewing tumors come back, it is usually within the first couple of years after treatment. But they can sometimes come back even many years later, so continued follow-up visits are important.
Physical therapy and rehabilitation are typically a very important part of recovery after treatment, and your doctors and other health providers will continue to monitor your (child’s) progress as time goes on.
Blood tests and other tests might be done as well. For example, the chemotherapy drug doxorubicin (Adriamycin) can affect the heart, so tests to measure heart function (such as echocardiograms) will probably be done as well.
During this time, it is very important to report any new symptoms to the doctor right away so that any problems can be found early, when they can be treated most effectively.
Talk with the treatment team about developing a survivorship care plan. This plan might include:
As much as you might want to put the experience behind you once treatment is completed, it’s also very important to keep good records of your (child’s) medical care during this time. Gathering these details soon after treatment may be easier than trying to get them at some point in the future. This can be very helpful later on if you (or your child) change doctors. Learn more about this in Keeping Copies of Important Medical Records.
It’s also very important to keep health insurance coverage. Tests and doctor visits can cost a lot, and even though no one wants to think of the tumor coming back, this could happen.
Treatment for a Ewing tumor might affect a person’s health later in life. Young people in particular are at risk for possible late effects of their treatment. This risk depends on many factors, such as the size and location of the cancer, the treatments received, doses of cancer treatment, and the person’s age when treated.
For example, the after-effects of surgery for Ewing tumors can range from small scars to the loss of a limb, which would require both physical rehabilitation and emotional adjustment.
Other late effects of treatment can include:
Other possible complications might come up as well. Your child’s doctor should carefully review any possible problems with you before starting treatment. For more information, see Late Effects of Childhood Cancer Treatment.
To help increase awareness of late effects and improve follow-up care for childhood cancer survivors throughout their lives, the Children’s Oncology Group (COG) has developed long-term follow-up guidelines for survivors of childhood cancers. These guidelines can help you know what to watch for, what types of screening tests should be done to look for problems, and how late effects can be treated.
It’s very important to discuss possible long-term complications with your child’s health care team, and to make sure there is a plan in place to watch for these problems and treat them, if needed. To learn more, ask your child’s doctors about the COG survivor guidelines. You can also read them on the COG website: www.survivorshipguidelines.org. The guidelines are written for health care professionals. Patient versions of some of the guidelines are available (as “Health Links”) on the site as well, but we urge you to discuss them with your doctor.
Most Ewing tumors develop during the teenage or young adult years, a very sensitive time in a person’s life. Ewing tumors and their treatment can have a profound effect on how a person looks and how they view themselves and their body. It can also affect how they do some everyday tasks, including certain school, work, or recreational activities. These effects are often greatest during the first year of treatment, but they can be long-lasting in some people. It’s important that the treating center assess the family situation as soon as possible, so that any areas of concern can be addressed.
These types of issues can often be addressed with support and encouragement. Doctors and other members of the health care team can also often recommend special support programs and services to help children, teens, and young adults after cancer treatment. For more information, see When Your Child's Treatment Ends.
No one chooses to have a Ewing tumor, but for many people, the experience can eventually produce some positive effects, helping to establish strong self-values. Other people may have a harder time recovering, adjusting to life after cancer, and moving on. It is normal to have some anxiety or other emotional reactions after treatment, but feeling overly worried, depressed, or angry can affect many parts of a young person’s growth. It can get in the way of relationships, school, work, and other aspects of life.
With support from family, friends, other survivors, mental health professionals, and others, many people who have survived cancer can thrive in spite of the challenges they’ve had to face.
Although Ewing tumors and their treatment can have social and emotional effects on children and teens (and their families), adults with this disease face many of the same challenges, and are also encouraged to take advantage of the cancer center’s physical therapy, occupational therapy, and counseling services.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Anderson ME, Dubois SG, Gebhart MC. Chapter 89: Sarcomas of bone. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
Gebhart MC, DuBois S. Treatment of the Ewing sarcoma family of tumors. UpToDate. 2021. Accessed at www.uptodate.com/contents/treatment-of-the-ewing-sarcoma-family-of-tumors on February 5, 2021.
National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Bone Cancer. Version 1.2021. Accessed at www.nccn.org/professionals/physician_gls/pdf/bone.pdf on February 5, 2021.
Last Revised: May 25, 2021
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.